Advent France Biotechnology (AFB) has held a EUR 86m first close for its second fund, which will continue the firm’s focus on European early-stage life sciences investments.
AFB holds EUR 86m first close for second fund
Most Popular
Advent France Biotechnology (AFB) has held a EUR 86m first close for its second fund, which will continue the firm’s focus on European early-stage life sciences investments.